DR Luke, D Hewlett Jr, V Welch, R Chambers… - Hospital …, 2011 - Thomas Land Abstract Objective: The aim of the study was to compare all-cause adverse events (AEs) and those caused by intravenous (IV) catheter-site complications (IVCSCs) using data from a previously published study of the use of linezolid or vancomycin for treatment of complicated skin ... Related articles
LC Smith, C Winsor - US Patent App. 13/006,315, 2011 - Google Patents US 20110112483A1 (i9) United States (12) Patent Application Publication oo) Pub. No.: US 2011/0112483 Al Smith et al. (43) Pub. Date: May 12,2011 (54) INTRAVENOUS CATHETER ANCHORING DEVICE (75) Inventors: (73) Assignee: (21) Appl.No.: (22) Filed: Larry C. ... All 2 versions
E Reynolds - JAMA: The Journal of the American Medical …, 2011 - Am Med Assoc Ms C had been discharged 10 days prior to receive a 2-week antibiotic course for a line infection. Seven days later, Ms C developed nausea and fatigue. The next morning, after a surveillance blood culture was reported positive, she called an ambulance and was transported to the ... All 2 versions
KA Peterson, AL Phillips, E Truemper… - Journal of Pediatric …, 2011 - Elsevier Peripheral intravenous (PIV) access is a common and essential component for the medical management of the hospitalized child. Delayed or failed PIV insertion can increase the risk for complications from delayed intravenous treatment. Repetitive PIV insertion attempts can cause ... All 2 versions
SW Means, MV Spampinato… - Advances in Neonatal …, 2011 - journals.lww.com Vascular access is critical in the care of sick infants and children for the direct administration of medications and fluids. In infants, especially preterm infants, the use of scalp veins is a common practice because of less subcutaneous fat and less mobility around the catheter site ...